# Propofol Induction Based on Lean Body Weight on the Depth of Anesthesia

> **NCT06862349** · PHASE4 · COMPLETED · sponsor: **Ankara City Hospital Bilkent** · enrollment: 120 (actual)

## Conditions studied

- Propofol Adverse Reaction

## Interventions

- **DRUG:** Group T received propofol at a dose of 2-2.5 mg/kg based on total body weight
- **DRUG:** Group L received propofol at 2-2,5mg/kg dose based on lean body weight, which was calculated from CT imaging by a radiologist.

## Key facts

- **NCT ID:** NCT06862349
- **Lead sponsor:** Ankara City Hospital Bilkent
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-01
- **Primary completion:** 2025-02-20
- **Final completion:** 2025-02-27
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06862349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06862349, "Propofol Induction Based on Lean Body Weight on the Depth of Anesthesia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06862349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*